These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 72048)

  • 1. Hydroxyethyl starch-induced macroamylasemia.
    Köhler H; Kirch W; Horstmann HJ
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):428-31. PubMed ID: 72048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperamylasemia following infusion of hydroxyethyl starch with different molecular weight distributions].
    Gofferje H; Kozlik V
    Infusionsther Klin Ernahr; 1977 Jun; 4(3):141-4. PubMed ID: 70402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.
    Ferber HP; Nitsch E; Förster H
    Arzneimittelforschung; 1985; 35(3):615-22. PubMed ID: 2581591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood volume replacement and hemodilution with hydroxyethyl starch].
    Messmer K; Jesch F
    Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroamylasemia induced by hydroxyethyl starch--confirmation by gel filtration analysis of serum and urine.
    Mishler JM; Dürr GH
    Am J Clin Pathol; 1980 Oct; 74(4):387-91. PubMed ID: 6158858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroamylasaemia after treatment with hydroxyethyl starch.
    Köhler H; Kirch W; Weihrauch TR; Prellwitz W; Horstmann HJ
    Eur J Clin Invest; 1977 Jun; 7(3):205-11. PubMed ID: 70354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
    Mishler JM; Dürr HK
    Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experiences with a 6% hydroxyethyl starch 40000 solution; metabolic parameters and tolerance].
    Kori-Lindner C; Hubert H
    Infusionsther Klin Ernahr; 1978 Apr; 5(2):93-8. PubMed ID: 77256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Second effect on volume after a one-time infusion of hydroxyethyl starch].
    Köhler H; Kirch W; Pitz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1756-8. PubMed ID: 77106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Macroamylasemia or pancreatitis? A diagnostic problem].
    Attanasio A; Castellaro I; Rizzotti P; Marini M; Vidal M
    Minerva Med; 1987 Sep; 78(18):1347-51. PubMed ID: 2443875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
    Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyethyl starch. Control of alpha-amylase hydrolysis and its subsequent clinical application.
    Mishler JM
    Acta Haematol Pol; 1980; 11(2):113-6. PubMed ID: 6158825
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formation of high-molecular aggregates between serum amylase and colloidal plasma substitutes (author's transl)].
    Köhler H; Kirch W; Horstmann HJ
    Anaesthesist; 1977 Nov; 26(11):623-7. PubMed ID: 74216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma.
    Volopich S; Mosing M; Auer U; Nell B
    Vet Ophthalmol; 2006; 9(4):239-44. PubMed ID: 16771759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
    Halmágyi M
    Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroamylasemia.
    Faro RS; Trafton HF; Organ CH
    Surgery; 1977 Nov; 82(5):552-4. PubMed ID: 918844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.